Talon Capital Corp. Appoints Independent Director Victoria Ivashina

What Happened

• Talon Capital Corp. announced that on September 9, 2026 its Board appointed Dr. Victoria Ivashina as an independent director, effective September 11, 2026. Dr. Ivashina was also appointed to the Board’s audit committee effective September 11, 2026.
• Dr. Ivashina is a finance academic and practitioner: Lovett‑Learned Professor of Finance at Harvard Business School since 2016, co‑head of HBS’s Private Capital Initiative, trustee of the Carlyle AlpInvest Private Markets funds since 2022, Research Associate at NBER since 2010, and holds a Ph.D. in Finance from NYU Stern.

Key Details

• Appointment effective date: September 11, 2026. Board action date: September 9, 2026.
• Ownership/compensation related: Talon Capital Sponsor LLC transferred 20,000 Class B ordinary shares to Dr. Ivashina at a purchase price of approximately $0.003 per share (Securities Assignment Agreement dated Sept 11, 2026).
• Governance mechanics: Dr. Ivashina signed joinders to the Company’s insider letter agreement and registration rights agreement (each dated Sept 8, 2025) and entered into the Company’s standard director indemnity agreement (form previously filed).
• Independence/no related-party: The Board determined she is an “independent director” under the Exchange Act and Nasdaq rules; the Company is not aware of any transaction involving Dr. Ivashina requiring Item 404(a) disclosure and reports no family relationships with Company officers or directors.

Why It Matters

• The appointment adds an independent director with deep academic and private‑capital expertise and places her on the audit committee, which may affect the Board’s oversight of financial reporting and fund-related matters.
• The equity transfer (20,000 Class B shares at ~$0.003 each) and the joinders to existing governance agreements establish her contractual and ownership ties to the Company; the filing indicates no related‑party disclosure issues were identified.